Cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: We searched three online databases: PubMed, CINAHL, and Web of Science. Search limits included peer-reviewed studies, published in English, by October 1st, 2021. The commencing year limit was not set, and all research articles were traced back. The inclusion criterion for the present review was the prospective study principally investigated the effects of chemotherapy on cognition for adults with cancer. However, studies that investigated other cancer treatments separately from chemotherapy were included if they had a chemotherapy treatment group alone.
Exclusion criteria
Exclusion criteria: The exclusion criteria for our study are as follows: (1) no abstract (2) languages other than English (3) review article, interventional trial, and case study (4) experiments with animals (5) primary brain tumor or brain metastasis (6) unclear distinction between hormone therapy and radiation therapy (7) having any other reason that the reviewer finds to be an obvious content discrepancy. As an example of this content inconsistency, in order to examine the effect of chemotherapy treatment on cognitive impairment more purely, we excluded cases in which the main topic of the previous study was considered by the reviewers to be strongly influenced by depression, anxiety, fatigue, or anemia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neuropsychological assessment tool | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient reported outcome Neuroimaging assessment tool | — |
Countries
Japan
Contacts
Hiroshima University Graduate school of Biomedical and Health Sciences